| Name | Title | Contact Details |
|---|
Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Its products include Ampligen, which is under clinical development for the treatment of Chronic Fatigue Syndrome, Hepatitis B, human immunodeficiency virus (HIV), renal cell carcinoma, and malignant melanoma; Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of certain categories of genital warts; and Alferon LDO, a low-dose oral liquid formulation of natural alpha interferon for the treatment of influenza and other emerging viral diseases. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.
Spectranetics is dedicated to managing every lead and eradicating restenosis and amputation. We do this by helping physicians, patients, and hospitals maximize cardiovascular health. Our company is committed to inventing, selling, and supporting technology that enables success during the most challenging minimally invasive cardiovascular procedures. We provide expert physician training, including the only lead removal simulator in the industry, as well as extensive patient and physician education. The Company’s Lead Management (LM) division is dedicated to helping physicians safely manage every lead. We provide the expert tools, training and ongoing support – including the only available lead extraction simulator – that allow physicians precision, control and versatility while extracting leads, so they can focus more on the patient’s overall status while generating positive outcomes. The Vascular Intervention (VI) division is dedicated to helping physicians address the challenges of peripheral and coronary artery disease. We provide expert tools, training, ongoing support, and patient education so that you can help eradicate restenosis and amputation
Meet Twiage: An award-winning mobile communication technology that enables hospitals and EMS to accelerate life-saving emergency care by reducing the need of radio and phone communication. Twiage offers Hospitals & Emergency Departments: - Real-time prehospital clinical data for Stroke, STEMI, Trauma, and Sepsis, as well as all other EMS transports - HIPAA-compliant Videos, Photos, and EKGs - Patient Pre-Registration - GPS-tagged ETA for every incoming ambulance, optimizing ED flow and triage - Two-way communication capabilities for intra-hospital care coordination and inter-facility transfers. Twiage offers EMS: - Faster handoffs and ED turnaround times - No more reliance on radios! - HIPAA-compliant video, photos, and data capture sent directly to entire hospital teams - Simple, evidence-driven algorithms that help improve quality handoffs - Ability to create custom algorithms to match your clinical protocols Awards: Pulse @ MassChallenge, Platinum Award, 2017 MATTER Chicago, Observation Unit Challenge - Winner, 2017 American Heart/Stroke Association, Health Tech Competition - People`s Choice Award, 2016 American Medical Association, Healthier Nation Challenge - 1st Place Winner, 2016 Aspen Institute, Spotlight Health Finalist, 2016 Cornell Venture Challenge - 2nd Place Winner, 2016 Cleveland Clinic, New Ventures Healthcare Challenge - Winner, 2015 Massachusetts Medical Society, Information Technology Award, 2014 mHealth, Rockstar of the Year for most meaningful mobile health technology, 2014
LifeBrands is a New York, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
NUCATS provides scientists with consultative resources and expertise in order to accelerate how quickly transformative scientific discoveries make their way to patients and the community. It is our goal to continually increase the quality, safety, efficiency and speed of innovative clinical and translational research.